Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001683168-22-002045
Filing Date
2022-03-29
Accepted
2022-03-29 13:44:02
Documents
47
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A nunz_i10ka-123120.htm   iXBRL 10-K/A 770087
2 CERTIFICATION PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 nunz_ex3101.htm EX-31.1 8504
3 CERTIFICATION PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 nunz_ex3102.htm EX-31.2 8689
4 CERTIFICATION nunz_ex3201.htm EX-32.1 5943
  Complete submission text file 0001683168-22-002045.txt   4252599

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE fil-20201231.xsd EX-101.SCH 28264
6 XBRL CALCULATION FILE fil-20201231_cal.xml EX-101.CAL 29031
7 XBRL DEFINITION FILE fil-20201231_def.xml EX-101.DEF 150941
8 XBRL LABEL FILE fil-20201231_lab.xml EX-101.LAB 196755
9 XBRL PRESENTATION FILE fil-20201231_pre.xml EX-101.PRE 205634
41 EXTRACTED XBRL INSTANCE DOCUMENT nunz_i10ka-123120_htm.xml XML 762246
Mailing Address 1627 WEST 14TH STREET LONG BEACH CA 90813
Business Address 1627 WEST 14TH STREET LONG BEACH CA 90813 714-609-9117
NUNZIA PHARMACEUTICAL Co (Filer) CIK: 0000886093 (see all company filings)

EIN.: 870442090 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39175 | Film No.: 22779615
SIC: 8741 Services-Management Services